NewsBlog: [Entry posted at 30th June 2008 05:30 PM GMT] A former US army biodefense researcher who was a "person of interest" in the still-unsolved case of the 2001 anthrax letters and who sued the government, claiming the investigation ruined his reputation, will receive a $5.8 million settlement from the Justice Department.
The FBI turned its attention on the researcher, Steven J. Hatfill, in 2002 as part of its investigation of the mysterious anthrax case that caused the death of five... Click to continue
|
NewsBlog: [Entry posted at 20th June 2008 07:56 PM GMT] Biotech tools company Invitrogen has appointed a team charged with integrating the company's operations with those of Applied Biosystems (AB), another biotech tools company, which Invitrogen acquired last week in a deal valued at a whopping $6.7 billion.
The announcement, made today (June 20) in a press release, marks the first step in the... Click to continue
|
NewsBlog: [Entry posted at 19th June 2008 07:55 PM GMT] Glial cells, long thought to be supporting actors to neurons, play a crucial role of their own in regulating neuronal activity, according to a study published in Science this week.
The study's results suggest that glial cells provide the link between neurons and the vasculature in the brain and central nervous system, and posit that the nervous system is controlled in a more complex manner than previously thought.
"For a hundred years, we have known that glia existed," said... Click to continue
|
Comment on this blog
NewsBlog: [Entry posted at 16th June 2008 03:04 PM GMT] Chimeric mice generated from cells reprogrammed for pluripotency (induced pluripotent stem cells, or iPS cells) show significant health problems, pointing to further challenges that must be overcome before such cells can be used in the clinic, noted iPS researcher Shinya Yamanaka said on Saturday (June 14).
Speaking at the meeting of the ... Click to continue
|
NewsBlog: [Entry posted at 11th June 2008 03:57 PM GMT] The US Senate today (June 11) plans to introduce a biosafety bill that takes small steps towards resolving some controversial aspects of the system regulating research with agents that could be used for bioterrorism.
The regulations, called the Select Agent Program, have been controversial since they were established in 2002. Researchers have said that the rules created red tape that stymied research, hindered international... Click to continue
|
NewsBlog: [Entry posted at 10th June 2008 09:53 PM GMT] With blockbuster drug patents set to expire in the next few years, big pharma is looking hard for ways to pack the discovery pipeline.
One approach: the biotech model. Patrick Vallance, the head of drug discovery at GlaxoSmithKline, said at a meeting on Friday (June 6) that research at the company would be reorganized to be "more biotech-like," the Financial Times reported. He said the plan was... Click to continue
|
|
Alla's blog
Alla Katsnelson
Location:
Philadelphia, USA
Who am I?
Associate Editor
Previous months
>> November 2008
>> October 2008
>> September 2008
>> August 2008
>> July 2008
>> June 2008
>> May 2008
>> April 2008
>> March 2008
>> February 2008
>> January 2008
>> December 2007
>> November 2007
>> October 2007
>> September 2007
>> August 2007
|
